-
Phenothiazines, ROS, and Autophagy in Macrophages
2026-08-15
The reference study identifies phenothiazines as host-directed lead compounds that strengthen macrophage antibacterial activity through coordinated reactive oxygen species accumulation, lysosomal activation, and autophagy. Pharmacological inhibition of autophagy or ROS substantially weakened this protection, while perphenazine reduced lesion and inflammatory outcomes in a Salmonella Typhimurium infection model.
-
SOAT1, Lipophagy, and PHMG-Induced Lung Fibrosis
2026-08-14
The reference study identifies sterol O-acyltransferase 1 (SOAT1) as a previously unrecognized driver of PHMG-induced pulmonary fibrosis. By linking SOAT1-dependent cholesteryl ester accumulation in alveolar macrophages to impaired lipophagy and fibroblast activation, the work supports SOAT1 inhibition as a preclinical therapeutic strategy.
-
Filipin III for Membrane Cholesterol Workflows
2026-08-14
Filipin III converts cholesterol distribution into an actionable imaging and membrane-fraction readout for macrophage, vesicle, and pulmonary injury studies. This guide connects cholesterol-rich membrane microdomain analysis with the SOAT1–lipophagy mechanism reported in PHMG-induced fibrosis while emphasizing controls, workflow timing, and interpretation limits.
-
ML365: From TASK1 Assay to Neuroinflammation
2026-08-13
ML365 links selective TASK1 potassium-channel pharmacology with experimental neuroinflammation research. This article presents an assay-triangulation framework that separates channel engagement, inflammasome biology, cognitive phenotype, and compound-specific confounding factors.
-
S-Adenosylmethionine: From Donor to Strategy
2026-08-13
S-Adenosylmethionine is more than a methyl donor: it is a controllable metabolic variable that can reveal enzyme selectivity, guide epigenetic assay design, and strengthen translational decisions. New mechanistic work on the mulberry methyltransferase MaMT4 shows why donor concentration, substrate architecture, and active-site context must be interpreted together.
-
Entinostat (MS-275): HDAC1/3 Research Workflows
2026-08-12
Entinostat (MS-275) combines strong HDAC1/3 activity with a practical workflow for profiling chromatin remodeling, cancer cell responses, and regeneration-linked biology. This guide connects quantitative assay design with troubleshooting strategies that help distinguish target engagement, growth suppression, and cell death.
-
D-Luciferin for Reliable Luciferase Assays
2026-08-12
Learn how D-Luciferin, SKU B6040, can improve the consistency of luciferase-based viability, proliferation, cytotoxicity, ATP, and imaging workflows. This scenario-driven guide covers assay principle, solvent compatibility, storage, optimization, data interpretation, and evidence-based reagent selection.
-
Bleomycin Sulfate: From DNA Damage to Fibrosis
2026-08-11
Bleomycin Sulfate is more than a DNA-damaging reagent: it is a translational bridge between genotoxic stress, tissue injury, and fibrotic remodeling. This article connects its established oncology and pulmonary fibrosis applications with recent evidence on adipose-tissue loss and the miR-4769-3p/USP18/VDAC2 axis in systemic sclerosis.
-
3X (DYKDDDDK) Peptide Workflow Guide
2026-08-11
The 3X (DYKDDDDK) Peptide is more than a detection reagent: it can serve as a specificity competitor, purification eluent, and assay-control standard for FLAG-tagged proteins. This guide connects those use cases to USP18–GSDMD pyroptosis research while emphasizing tag placement, metal sensitivity, and reproducible troubleshooting.
-
Etomoxir: CPT-1 Inhibition in Metabolic Research
2026-08-10
Etomoxir, also called R-(+)-Etomoxir, is a cell-permeable, irreversible CPT-1 inhibitor used to interrogate mitochondrial fatty acid oxidation. Its reported DGAT activity and model-dependent effects require concentration controls, orthogonal flux assays, and cautious interpretation in immunometabolism and EAE studies.
-
NS1–DNMT1 Control of HBoV1 Replication
2026-08-09
A 2024 PLOS Pathogens study identifies DNMT1-dependent DNA methylation as a regulator of human bocavirus 1 replication and RNA processing. The work further shows that HBoV1 NS1 redirects this pathway by promoting DNMT1 degradation through the ubiquitin–proteasome system, linking viral DNA synthesis with transcript maturation and protein expression.
-
YC-1 Hypoxia Signaling: Workflow & Troubleshooting
2026-08-08
YC-1 connects hypoxia-inducible signaling with soluble guanylyl cyclase biology, making it useful for mechanism-focused cancer research rather than single-endpoint screening. This guide shows how to formulate, dose, validate, and troubleshoot YC-1 experiments spanning HIF-1α regulation, cGMP responses, apoptosis, and tumor angiogenesis inhibition.
-
Bradford Protein Assay Kit: Practical Workflow
2026-08-07
The Bradford Protein Assay Kit (SKU K4103) provides a rapid protein concentration measurement workflow using Coomassie Brilliant Blue G-250 and only 5 µL of sample or standard. It is suitable for soluble protein samples, enzyme assays, purification checks, and molecular biology workflows, but detergent-rich or chemically incompatible matrices require separate compatibility testing.
-
AP20187: Precision Chemical Inducer of Dimerization in Gene
2026-08-07
AP20187 empowers researchers with programmable control over protein dimerization and gene regulation in both in vitro and in vivo models. Its high solubility, rapid action, and validated performance in metabolic and cell therapy research set it apart as an essential conditional gene therapy activator.
-
Vardenafil HCl Trihydrate: Precision PDE5 Inhibition in Smoo
2026-08-06
Vardenafil HCl Trihydrate empowers researchers to dissect cGMP signaling and smooth muscle relaxation with unmatched selectivity and potency. This guide details experimental workflows, advanced use cases, and troubleshooting tips, integrating proteoform-specific targeting for next-generation translational studies.